At 85
Astatine was discovered in 1940 by a team of American chemists, Emilio Segrè, Glen T. Seaborg, and Albert Ghiorso, at the University of California, Berkeley. The team first synthesized the element by bombarding bismuth with alpha particles. The name 'astatine' is derived from the Greek word 'astatos,' meaning 'unstable,' reflecting its short half-life. Astatine was first identified in trace amounts and has remained one of the least understood elements due to its extreme rarity and radioactive properties. The discovery of astatine added depth to the understanding of heavy elements and their isotopes, expanding the table of elements in the periodic system.
Astatine is extremely rare in nature, and it is estimated that there are only about 25 grams of astatine present in the Earth's crust at any given time. It is typically found in uranium and thorium ores as a decay product of natural radioactivity. The isotopes of astatine are chiefly produced in trace amounts through the decay of heavier elements or created artificially in laboratory settings. Its presence is fleeting, as most of its isotopes have short half-lives, leading to its rapid decay and making it challenging to detect and study.
Astatine's biological role remains largely unstudied due to its rarity and radioactivity; however, it is suspected to have limited significance in biological systems. Some research suggests that astatine could interfere with biological macromolecules, particularly DNA, due to its radioactive particles and the potential to cause ionization damage. Some isotopes of astatine have been explored for their potential use in targeted alpha-particle therapy for cancer treatment, where their radioactive properties can be harnessed for therapeutic purposes, indicating a possible important role in medicine despite limited current applications.
Astatine is a metalloid, and its physical properties are not well-established due to its extreme rarity and radioactivity. It is predicted to be a solid at room temperature, with a black or dark brown appearance. Astatine exhibits properties typical of halogens, including reactivity and the ability to form diatomic molecules, although it is much less reactive compared to lighter halogens like chlorine and bromine. It has a relatively high atomic mass of about 210 grams per mole and is known to have a melting point estimated at around 105 °C and a boiling point estimated at 337 °C, though these values remain somewhat uncertain due to the element's instability.
The primary applications of astatine are in special research and medical fields due to its radioactive properties. Astatine-211, one of its isotopes, shows promise in radioimmunotherapy, a type of cancer treatment that exploits the element’s ability to emit alpha particles to target and destroy cancerous cells while minimizing damage to surrounding healthy tissue. This is still a developing area of research, with the potential for greater therapeutic applications as techniques improve. Additionally, as a rare element, astatine has been the subject of scientific interest in nuclear chemistry and related fields.